Promega Corporation

AKT1 Kinase Enzyme System

See All Kinase Enzyme Systems
Recombinant full-length human AKT1 was expressed by baculovirus in Sf9 insect cells using an N-terminal GST tag. AKT1/PKBα is a serine/threonine kinase that belongs to the AKT family. AKT1 is activated in cells in response to diverse stimuli such as hormones, growth factors and extracellular matrix components and is involved in glucose metabolism, transcription, survival, cell proliferation, angiogenesis and cell motility. AKT1 is frequently overexpressed and active in many types of human cancers including cancers of colon, breast, brain, pancreas and prostate as well as lymphomas an...

Expand to Read More »

  • Share
  • Print
  • Email
  • Products
  • Specifications
  • Product Resources
  • Patents & Disclaimers
  • Prices valid for customers of Promega GmbH only
Product Size Conc. Catalog # *List Price Order QTY Add to Cart

AKT1 Kinase Enzyme System

Close Window

AKT1 Kinase Enzyme System

 Components

10μg
- V1911 € 357,00 Add to cart

ADP-Glo™ Kinase Assay + AKT1 Kinase Enzyme System

Close Window

ADP-Glo™ Kinase Assay + AKT1 Kinase Enzyme System

 Components

  • AKT1 Kinase Enzyme System

    V19111 x 10μg
  • ADP-Glo™ Kinase Assay

    V91011 x 1,000 assays
1 each
- V9061 € 724,00 Add to cart


You Also May Be Interested In

Storage Conditions

Upon receipt, centrifuge the kinase and dispense it into smaller quantities. Store the kinase at –70°C and the rest of the components at –20°C.

For product intended use please see Patents & Disclaimers tab.

Use Restrictions

V1911, V9061 For Research Use Only. Not for Use in Diagnostic Procedures.

Patents - Disclaimers

For Cat.# V9061:

Patents Pending.

U.S. Pat. No. 7,700,310 and other patents and patents pending.

U.S. Pat. Nos. 6,602,677, 7,241,584 and 8,030,017 and other patents and patents pending.

U.S. Pat. Nos. 7,083,911, 7,452,663 and 7,732,128 and other patents.

U.S. Pat. No. 7,741,067 and other patents and patents pending.

The method of recombinant expression of Coleoptera luciferase is covered by U.S. Pat. Nos. 5,583,024, 5,674,713 and 5,700,673.

Licensed from Lonza Nottingham Ltd. under U.S. Pat. Nos. 6,599,711 and 6,911,319 and other pending and issued patents.

Prefer a different language?

Your country is set to Germany. Your language is set to Deutsch. Please select the language that will best suit your needs:

This is correct, continue to site »

I need additional help

  • Warning
  • It appears that you have Javascript disabled. Our website requires Javascript to function correctly. Please enable Javascript to experience our website.